Carmignac Gestion

SEC CIK: 0001569758
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

CLSD holding history

Clearside Biomedical, Inc. in every 13F filed by Carmignac Gestion, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLSD overview All 13F holders of CLSD Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 19; Since Q1 2021

Holdings of CLSD by Carmignac Gestion, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−100,556−100.0%	Sold out	Holders
Q3 2025	100,556	$399.2K	<0.1%	00.0%	UnchangedConverted for a 1-for-15 split	Holders
Q2 2025	1,508,342	$1.21M	<0.1%	00.0%	Unchanged	Holders
Q1 2025	1,508,342	$1.38M	<0.1%	−425,189−22.0%	Reduced	Holders
Q4 2024	1,933,531	$1.84M	<0.1%	00.0%	Unchanged	Holders
Q3 2024	1,933,531	$2.46M	<0.1%	−199,213−9.3%	Reduced	Holders
Q2 2024	2,132,744	$2.77M	<0.1%	00.0%	Unchanged	Holders
Q1 2024	2,132,744	$3.26M	0.1%	00.0%	Unchanged	Holders
Q4 2023	2,132,744	$2.50M	<0.1%	00.0%	Unchanged	Holders
Q3 2023	2,132,744	$1.86M	<0.1%	−267,600−11.1%	Reduced	Holders
Q2 2023	2,400,344	$2.69M	<0.1%	00.0%	Unchanged	Holders
Q1 2023	2,400,344	$2.50M	<0.1%	00.0%	Unchanged	Holders
Q4 2022	2,400,344	$2.69M	<0.1%	00.0%	Unchanged	Holders
Q3 2022	2,400,344	$2.71M	0.1%	+10,000+0.4%	Added	Holders
Q2 2022	2,390,344	$3.51M	0.1%	−95,308−3.8%	Reduced	Holders
Q1 2022	2,485,652	$5.69M	0.1%	00.0%	Unchanged	Holders
Q4 2021	2,485,652	$6.84M	0.1%	+10,000+0.4%	Added	Holders
Q3 2021	2,475,652	$14.9M	0.2%	−944,225−27.6%	Reduced	Holders
Q2 2021	3,419,877	$16.7M	0.2%	−121,084−3.4%	Reduced	Holders
Q1 2021	3,540,961	$8.75M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.